混合冠状动脉再血管化的现状
Robin Willard1, Joshua Scheinerman2, Stevan Pupovac3
1Department of Cardiovascular & Thoracic Surgery, Lenox Hill Hospital/Northwell Health, New York, New York.
The Annals of thoracic surgery
|April 27, 2024
概括
混合冠状动脉再血管 (HCR) 提供与绕道手术相比的生存率,更好地利用资源,减少短期疾病. 它还可以减少重复手术与皮肤冠状动脉干预 (PCI) 相比.
科学领域:
- 心脏病学 心脏病学
- 心血管外科心血管外科
- 干预心脏病学 干预心脏病学
背景情况:
- 混合冠状动脉再血管化 (HCR) 结合了对多血管冠状动脉疾病的微创手术和皮肤冠状动脉干预 (PCI).
- 尽管HCR已被广泛使用,但其广泛采用仍然有限.
- 对HCR与传统冠状动脉绕道移植 (CABG) 手术和多血管PCI进行比较分析至关重要.
研究的目的:
- 为了比较评估混合冠状动脉再血管 (HCR) 与传统冠状动脉旁路移植 (CABG) 手术和多血管皮肤冠状动脉干预 (PCI).
- 评估HCR在治疗多血管冠状动脉疾病中的疗效,安全性和资源利用.
主要方法:
- 审查现有研究,比较HCR与CABG和多容器PCI.
- 对资源利用,短期发病率和中长期存活率的数据进行分析.
- 评估周围手术发病率和需要重复复血管化的情况.
主要成果:
- 在中长期中,HCR的生存率与传统的CABG相比相当.
- 与CABG相比,HCR可能在资源利用和短期发病率方面具有优势.
- HCR表现出与PCI相似的周围手术发病率,但可能通过手术动脉移植减少重复血管化.
结论:
- 在多血管冠状动脉疾病中,HCR提供了一个可行的替代方案,平衡了手术和干预方法的好处.
- 需要进一步进行大规模随机试验,以巩固HCR在临床实践中的地位.
- 通过将动脉移植的耐用性与PCI的精度相结合,HCR可以优化治疗策略.
相关概念视频
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...